[O2-4] SARS2-3

[O2-4-2] Characterization of Vero cells-adapted SARS-CoV-2 strain

*Shohei Minami¹, Tomohiro Kotaki¹, Shinya Okamura², Shiho Torii³, Chikako Ono^4,5, Daisuke Motooka⁶, Ryotaro Nouda¹, Moeko Yamasaki¹, Yuta Kanai¹, Hirotaka Ebina^2,5, Yusuke Maeda^5,7, Toru Okamoto^5,8, Yoshiharu Matsuura^4,5, Takeshi Kobayashi^1,5 (1. Department of Virology, Research Institute for Microbial Diseases, Osaka University, 2. Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, 3. Insect-Virus Interactions Unit, Institut Pasteur, 4. Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, 5. Center for Infectious Disease Education and Reseach, Osaka University, 6. Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, 7. Laboratory of Viral Dynamism Research, Research Institute for Microbial Diseases Osaka University, 8. Institute for Advanced Co-creation Studies, Research Institute for Microbial Diseases Osaka University)